Read this company snapshot
Daily valuation snapshot
BioNexus Gene Lab Corp Common stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $1.29
- Market capitalization (USD)
- $3,784,140.18
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.49
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BGLC in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research BGLC in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing BGLC with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $1.29 |
| Market capitalization (USD) | $3,784,140.18 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.49 |
No matching rows. Clear the filter to see all records.
Read BGLC's valuation metrics
Company size
BioNexus Gene Lab Corp Common stock's recorded market capitalization is $3,784,140.18. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
BGLC's recorded price-to-book ratio is 0.49. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research BioNexus Gene Lab Corp Common stock with Aurora
Use the snapshot above to ask a specific question about BGLC. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow BGLC's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.